Bill Breitenbach

Oral Biolife is an innovative biotech company utilizing Piezo materials to develop a groundbreaking product, Ambrilux Dental Gel for the treatment of periodontal disease. OralBiolife's In-vivo studies have demonstrated bone regeneration measuring the distance between the bone line and a tooth reference. Calculated as a ratio before/after treatment. The results are astounding! After one month of therapy, Ambrilux Dental Gel showed a significant reduction in the exposed dental roots compared to the clinical standard. Our In-vivo data, demonstrates that Ambrilux Dental Gel is a superior treatment for periodontitis because of its unique regenerative bone properties. Since Ambrilux Dental Gel catalyzes bone regeneration, it has a significant medical and commercial advantage over existing non-surgical treatments. Oral Biolife has developed a Platform with this Technology: The bone-regenerating technology may be applied to many applications that require a sterile, high-quality seal with bone, including dental and orthopedic implants. The remineralization activity may also be applied to dental sealants and composite restorations.